590 related articles for article (PubMed ID: 16446014)
21. Issues with reducing the rotavirus-associated mortality by vaccination in developing countries.
Naghipour M; Nakagomi T; Nakagomi O
Vaccine; 2008 Jun; 26(26):3236-41. PubMed ID: 18472196
[TBL] [Abstract][Full Text] [Related]
22. Rotavirus vaccines: recent developments and future considerations.
Angel J; Franco MA; Greenberg HB
Nat Rev Microbiol; 2007 Jul; 5(7):529-39. PubMed ID: 17571094
[TBL] [Abstract][Full Text] [Related]
23. Efficient intranasal immunization of newborn mice with recombinant adenovirus expressing rotavirus protein VP4 against oral rotavirus infection.
Liu X; Yang T; Sun QM; Sun MS
Acta Virol; 2005; 49(1):17-22. PubMed ID: 15929394
[TBL] [Abstract][Full Text] [Related]
24. A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children.
Steele AD; Cunliffe N; Tumbo J; Madhi SA; De Vos B; Bouckenooghe A
J Infect Dis; 2009 Nov; 200 Suppl 1():S57-62. PubMed ID: 19817615
[TBL] [Abstract][Full Text] [Related]
25. Mucosal and systemic antibody responses and protection induced by a prime/boost rotavirus-DNA vaccine in a gnotobiotic pig model.
Yuan L; Azevedo MS; Gonzalez AM; Jeong KI; Van Nguyen T; Lewis P; Iosef C; Herrmann JE; Saif LJ
Vaccine; 2005 Jun; 23(30):3925-36. PubMed ID: 15917114
[TBL] [Abstract][Full Text] [Related]
26. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.
Paulke-Korinek M; Kundi M; Rendi-Wagner P; de Martin A; Eder G; Schmidle-Loss B; Vecsei A; Kollaritsch H
Vaccine; 2011 Mar; 29(15):2791-6. PubMed ID: 21320539
[TBL] [Abstract][Full Text] [Related]
27. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
Chandran A; Santosham M
Expert Rev Vaccines; 2008 Dec; 7(10):1475-80. PubMed ID: 19053204
[TBL] [Abstract][Full Text] [Related]
28. Rotavirus.
Parashar UD; Bresee JS; Gentsch JR; Glass RI
Emerg Infect Dis; 1998; 4(4):561-70. PubMed ID: 9866732
[TBL] [Abstract][Full Text] [Related]
29. Serum antibody as a marker of protection against natural rotavirus infection and disease.
Velázquez FR; Matson DO; Guerrero ML; Shults J; Calva JJ; Morrow AL; Glass RI; Pickering LK; Ruiz-Palacios GM
J Infect Dis; 2000 Dec; 182(6):1602-9. PubMed ID: 11069230
[TBL] [Abstract][Full Text] [Related]
30. Assessing the introduction of universal rotavirus vaccination in the Netherlands.
Zomer TP; van Duynhoven YT; Mangen MJ; van der Maas NA; Vennema H; Boot H; de Melker HE
Vaccine; 2008 Jul; 26(29-30):3757-64. PubMed ID: 18514975
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of an ideal rotavirus vaccine.
Reisinger KS; Block SL
Clin Pediatr (Phila); 2008 Jul; 47(6):555-63. PubMed ID: 18467670
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of circulating intestinally committed memory B cells in children vaccinated with attenuated human rotavirus vaccine.
Rojas OL; Caicedo L; Guzmán C; Rodríguez LS; Castañeda J; Uribe L; Andrade Y; Pinzón R; Narváez CF; Lozano JM; De Vos B; Franco MA; Angel J
Viral Immunol; 2007; 20(2):300-11. PubMed ID: 17603846
[TBL] [Abstract][Full Text] [Related]
33. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants.
Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513
[TBL] [Abstract][Full Text] [Related]
34. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM
Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194
[TBL] [Abstract][Full Text] [Related]
35. Rotavirus infection: an update on management and prevention.
Dennehy PH
Adv Pediatr; 2012; 59(1):47-74. PubMed ID: 22789574
[TBL] [Abstract][Full Text] [Related]
36. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.
Patel MM; Clark AD; Glass RI; Greenberg H; Tate J; Santosham M; Sanderson CF; Steele D; Cortese M; Parashar UD
Vaccine; 2009 May; 27(22):2916-22. PubMed ID: 19428901
[TBL] [Abstract][Full Text] [Related]
37. The pentavalent rotavirus vaccine, RotaTeq.
Matson DO
Semin Pediatr Infect Dis; 2006 Oct; 17(4):195-9. PubMed ID: 17055370
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of IFN-gamma response to rotavirus and non-structural protein NSP4 of rotavirus in children following severe rotavirus diarrhea.
Malik J; Gupta SK; Bhatnagar S; Bhan MK; Ray P
J Clin Virol; 2008 Oct; 43(2):202-6. PubMed ID: 18693134
[TBL] [Abstract][Full Text] [Related]
39. Rotavirus immune responses and correlates of protection.
Angel J; Franco MA; Greenberg HB
Curr Opin Virol; 2012 Aug; 2(4):419-25. PubMed ID: 22677178
[TBL] [Abstract][Full Text] [Related]
40. The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.
Clark HF; Offit PA; Plotkin SA; Heaton PM
Pediatr Infect Dis J; 2006 Jul; 25(7):577-83. PubMed ID: 16804425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
